1 / 14

Humana, Inc. (HUM)

Analyzing Humana, Inc.'s investment potential in the evolving healthcare landscape, with insights on recent acquisitions, market expansion, valuation, catalysts, risks, and key industry metrics.

shea
Download Presentation

Humana, Inc. (HUM)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Lead Analyst: Charles Paraboschi| Associates: Robert Kost & Peter Blicharz Humana, Inc. (HUM) Healthcare (Health care providers)

  2. Investment Thesis • Best positioned in new healthcare environment • Accelerated enrollment growth • Recent acquisition and new contract open new markets • Undervalued in comparison to its peers and history

  3. Catalysts And Risks

  4. New Regulations • 68B Industry Tax/Fee for duration of 3 years • 80% min. medical cost ratio • Mandatory rebates • Cuts to charges on Brand name Drugs under part D • Periodic actuarial adjustments to re- imbursement rates

  5. Medical Care Ratio • Increase attributed to increase in consolidated benefit ratio in Humana’s Retail Segment.

  6. Administration Ratio

  7. Membership Changes

  8. Segments

  9. Value Metric P/1M Members

  10. Value Metric: Peer P/BV

  11. Value Metric: Historical P/B

  12. Value Metric: Historical P/Revenue

  13. Value Metric: Industry P/E

  14. Lead Analyst: Charles Paraboschi| Associates: Robert Kost & Peter Blicharz Humana, Inc. (HUM) Questions? Healthcare (Health care providers)

More Related